| Typicality: | 0.295 |
| Saliency: | 0.311 |
| in episodic and chronic migraine | 5 | location |
| for mers patients | 3 | transitive-object |
| antibody → shown → efficacy | 8 |
| antibody → show → efficacy | 4 |
| antibody → prove → therapeutic | 3 |
| negative | neutral | positive |
| 0.009 | 0.315 | 0.677 |
| Raw frequency | 15 |
| Normalized frequency | 0.311 |
| Modifier score | 0.500 |
| Perplexity | 465.430 |